JP2015120685A5 - - Google Patents

Download PDF

Info

Publication number
JP2015120685A5
JP2015120685A5 JP2014236875A JP2014236875A JP2015120685A5 JP 2015120685 A5 JP2015120685 A5 JP 2015120685A5 JP 2014236875 A JP2014236875 A JP 2014236875A JP 2014236875 A JP2014236875 A JP 2014236875A JP 2015120685 A5 JP2015120685 A5 JP 2015120685A5
Authority
JP
Japan
Prior art keywords
embolism
thrombosis
venous
thromboembolic
arterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014236875A
Other languages
English (en)
Japanese (ja)
Other versions
JP6337750B2 (ja
JP2015120685A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014236875A priority Critical patent/JP6337750B2/ja
Priority claimed from JP2014236875A external-priority patent/JP6337750B2/ja
Publication of JP2015120685A publication Critical patent/JP2015120685A/ja
Publication of JP2015120685A5 publication Critical patent/JP2015120685A5/ja
Application granted granted Critical
Publication of JP6337750B2 publication Critical patent/JP6337750B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014236875A 2013-11-22 2014-11-21 化合物 Expired - Fee Related JP6337750B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014236875A JP6337750B2 (ja) 2013-11-22 2014-11-21 化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013241680 2013-11-22
JP2013241680 2013-11-22
JP2014236875A JP6337750B2 (ja) 2013-11-22 2014-11-21 化合物

Publications (3)

Publication Number Publication Date
JP2015120685A JP2015120685A (ja) 2015-07-02
JP2015120685A5 true JP2015120685A5 (cg-RX-API-DMAC7.html) 2017-06-29
JP6337750B2 JP6337750B2 (ja) 2018-06-06

Family

ID=53532687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014236875A Expired - Fee Related JP6337750B2 (ja) 2013-11-22 2014-11-21 化合物

Country Status (1)

Country Link
JP (1) JP6337750B2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6479763B2 (ja) 2013-03-25 2019-03-06 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 第xia因子阻害剤としての置換アゾール含有のテトラヒドロイソキノリン
NO2760821T3 (cg-RX-API-DMAC7.html) 2014-01-31 2018-03-10
JP6505727B2 (ja) 2014-01-31 2019-04-24 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company ヘテロ環式p2’基を有する第xia因子阻害剤としてのマクロ環
JP6526796B2 (ja) 2014-09-04 2019-06-05 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Fxia阻害剤であるジアミドマクロ環
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
JP7179721B2 (ja) 2016-06-21 2022-11-29 オリオン・オフサルモロジー・エルエルシー 複素環式プロリンアミド誘導体
JP7164521B2 (ja) 2016-06-21 2022-11-01 オリオン・オフサルモロジー・エルエルシー 炭素環式プロリンアミド誘導体
EP4494698A3 (en) * 2017-08-04 2025-04-23 Takeda Pharmaceutical Company Limited Inhibitors of plasma kallikrein and uses thereof
TW202024062A (zh) 2018-09-20 2020-07-01 日商小野藥品工業股份有限公司 4-({(4s)-1-(4-甲脒基苯甲醯基)-4-[4-(甲磺醯基)哌-1-基]-l-脯胺醯基}胺基)苯甲酸之新穎鹽及其新穎結晶型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004517060A (ja) * 2000-11-07 2004-06-10 ブリストルーマイヤーズ スクイブ カンパニー セリンプロテアーゼ抑制剤として有用な酸誘導体
US7557222B2 (en) * 2003-06-18 2009-07-07 Merck Patent Gmbh 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
PL2051975T3 (pl) * 2006-05-16 2013-01-31 Boehringer Ingelheim Int Podstawione prolinamidy, ich wytwarzanie oraz ich zastosowanie jako środków leczniczych
TW201011006A (en) * 2008-06-16 2010-03-16 Nuevolution As IAP binding compounds
GB201209138D0 (en) * 2012-05-24 2012-07-04 Ono Pharmaceutical Co Compounds

Similar Documents

Publication Publication Date Title
JP2015524443A5 (cg-RX-API-DMAC7.html)
RU2014152276A (ru) Замещенные пирролидины в качестве ингибиторов фактора xia для лечения тромбоэмболических заболеваний
JP2010526103A5 (cg-RX-API-DMAC7.html)
JP2017222722A5 (cg-RX-API-DMAC7.html)
JP2014530240A5 (cg-RX-API-DMAC7.html)
EA201892505A1 (ru) Амидозамещенные производные пиридинилтриазола и их применение
RU2017124150A (ru) Производное дигидроиндолизинона
JP2017517512A5 (cg-RX-API-DMAC7.html)
TW201613932A (en) Organic compounds
CR20220096A (es) Proteínas de fusión terapéuticas
JP2018514535A5 (cg-RX-API-DMAC7.html)
JP2019519533A5 (cg-RX-API-DMAC7.html)
JP2017505809A5 (cg-RX-API-DMAC7.html)
MY195760A (en) Use of IDHP in Preparation of Drug or Health Product for Prevention and Treatment of Coronary Atherosclerosis Disease
JP2010513430A5 (cg-RX-API-DMAC7.html)
JP2016512243A5 (cg-RX-API-DMAC7.html)
Yap et al. A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation
JP2020500907A5 (cg-RX-API-DMAC7.html)
JP2017509701A5 (cg-RX-API-DMAC7.html)
JP2017508768A5 (cg-RX-API-DMAC7.html)
JP2016523943A5 (cg-RX-API-DMAC7.html)
JP2018513175A5 (cg-RX-API-DMAC7.html)
NZ733574B2 (en) Dihydroindolizinone derivative
JP2008524228A5 (cg-RX-API-DMAC7.html)
CN309502516S (zh) 书柜(祥竹)